Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
- This proficiency challenge is for laboratories performing gene panels, exome sequencing, and whole genome sequencing to detect germline variants associated with inherited forms of cardiomyopathy.
- Participants will be asked to identify variants in the following genes: MYBPC3, MYH7, TNNI3, TNNT2, and TPM1.
- Three 80.0-μL purified extracted DNA specimens (50 ng/μL)
Shipment A: April 16
Shipment B: October 15